Acute delta hepatitis during treatment with adenosine arabinoside monophosphate with resolution of the HBsAg carrier state.
Garcia
G
G
Department of Medicine, Stanford University School of Medicine, CA 94305-5100.
Smedile
A
A
Bergmann
K F
KF
Gerin
J L
JL
Gregory
P B
PB
Merigan
T C
TC
Robinson
W S
WS
D000208:Acute Disease; D000328:Adult; D001088:Arabinonucleotides / Q000627:therapeutic use*; D002353:Carrier State; D002908:Chronic Disease; D006514:Hepatitis B Surface Antigens / Q000032:analysis*; D003699:Hepatitis D / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D008297:Male; D001084:Vidarabine Phosphate / Q000008:administration & dosage / Q000627:therapeutic use*
D001088:Arabinonucleotides; D006514:Hepatitis B Surface Antigens; D001084:Vidarabine Phosphate